Cargando…
Neutralization of Human Cytomegalovirus Entry into Fibroblasts and Epithelial Cells
Human cytomegalovirus (HCMV) is a leading cause of permanent birth defects, highlighting the need to develop an HCMV vaccine candidate. However, HCMV vaccine development is complicated by the varying capacity of neutralizing antibodies (NAb) to interfere in vitro with the HCMV entry routes mediating...
Autores principales: | Wussow, Felix, Chiuppesi, Flavia, Contreras, Heidi, Diamond, Don J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748606/ https://www.ncbi.nlm.nih.gov/pubmed/29088098 http://dx.doi.org/10.3390/vaccines5040039 |
Ejemplares similares
-
Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice
por: Chiuppesi, Flavia, et al.
Publicado: (2017) -
Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex
por: Wussow, Felix, et al.
Publicado: (2014) -
Modeling Human Cytomegalovirus-Induced Microcephaly in Human iPSC-Derived Brain Organoids
por: Sun, Guoqiang, et al.
Publicado: (2020) -
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts
por: Reuter, Nina, et al.
Publicado: (2022) -
Synthetic multiantigen MVA vaccine COH04S1 and variant-specific derivatives protect Syrian hamsters from SARS-CoV-2 Omicron subvariants
por: Wussow, Felix, et al.
Publicado: (2023)